TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%
RELIANCE₹1,377.50▲ 14.60%TCS₹2,376.20▼ 3.44%HDFCBANK₹846.00▲ 18.82%ICICIBANK₹1,640.00▲ 18.75%INFY₹1,098.00▼ 2.89%HINDUNILVR₹2,052.50▲ 10.75%ITC₹299.10▲ 14.69%SBIN₹1,165.10▲ 19.66%BHARTIARTL₹2,161.70▲ 15.28%KOTAKBANK₹515.80▲ 16.62%LT₹4,209.10▲ 14.94%AXISBANK₹1,446.00▲ 16.99%ASIANPAINT₹2,608.30▲ 11.91%MARUTI₹14,011.00▲ 22.10%AAPL$342.56▲ 0.90%MSFT$484.52▼ 8.90%GOOGL$265.29▼ 22.04%AMZN$246.82▼ 6.02%NVDA$125.53▼ 42.01%META$560.84▼ 19.22%TSLA$345.82▼ 7.46%BRK-B$570.00▲ 5.59%JPM$310.53▼ 7.38%V$401.87▼ 1.16%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸ABT

Abbott Laboratories Common Stock

NYSE
$103.87
▼ $0.19 (-0.2%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 19 Nov 2026
H $117.34L $84.05+23.1%
$117.34$110.68$104.02$97.37$90.71$84.05$104.47
RSI (14)
Intraday · 15-minSell-15RSI 42DowntrendMACD Bullishfor day-trading context — not advice

Technical signal

Buy+35
RSI (14)45
oversold 30overbought 70
Trend
Uptrend
MACD
Bearish
Bollinger
Within bands
vs 20-day
below
vs 50-day
above
vs 200-day
above
Support
$101.54
Resistance
$117.07
  • Price is above its 50-day average (medium-term uptrend).
  • Price is above its 200-day average (long-term uptrend).

Signal backtest · 2026-02-18 → 2026-11-19

Strategy return
+13.7%
Buy & hold
-7.8%
Trades
3
Win rate
33%

$100,000.00 invested would be worth $113,657.03 (+13.7%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Abbott Laboratories· Medical Devices

source: yahoo

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Sector
Healthcare
Industry
Medical Devices
Employees
122,000
Headquarters

Fundamentals

source: yahoo
Market cap
$178.39B
P/E
38.4
P/B
3.5
EPS
$2.68
Div yield
2.5%
Profit margin
9.7%
ROE
9.1%
Debt / Equity
0.61
Beta
0.54
52-week range
$81.97 – $129.85
52-week low · $81.9746% of rangehigh · $129.85

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:▲ Positive1↑ · 0↓ · 7–
  • Why You Should Think About Boston Scientific Differently Now— Neutral
    Trefis · 19 Nov 2026
  • Global Point-of-Care Connectivity Solutions Market to Reach $1.7 Billion by 2032 | Abbott, Roche, Siemens Healthineers and GE HealthCare Accelerate AI-Driven Care— Neutral
    GlobeNewswire · 19 Nov 2026
  • Point-of-Care/Rapid Diagnostics - Global Strategic Business Report 2026: Capture a $40.7 Billion Market by 2032 with Abbott, Roche, Danaher and Siemens— Neutral
    GlobeNewswire · 19 Nov 2026

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

Abbott Park, United States
www.abbott.com ↗
Nerve Repair and Regeneration Devices - Global Strategic Business Report: Secure Share of a $17.6B Market by 2030 as Abbott, Boston Scientific, Collagen Matrix and Inspire Medical Accelerate— Neutral
GlobeNewswire · 19 Nov 2026
  • Anthropic initiated, MongoDB upgraded: Wall Street's top analyst calls▲ Positive
    The Fly · 19 Nov 2026
  • Global Clinical-Grade Wearables for Pharma and Biotech Market Report 2026 | Capitalize on 21.5% CAGR to $7.48B by 2030 as Abbott, Medtronic, DexCom and Philips Scale AI-Driven RPM— Neutral
    GlobeNewswire · 19 Nov 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.